AnticoagEvaluator: A Comprehensive Tool for Anti-Thrombotic Therapy Decisions
AnticoagEvaluator is a free medical app developed by the American College of Cardiology Foundation for Android devices. The app is designed to help healthcare professionals make well-informed decisions on anticoagulant therapy for non-valvular atrial fibrillation (AF) patients. AnticoagEvaluator provides a range of features, including calculating a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed. It also offers ACC/AHA/HRS guideline-driven therapy guidance for stroke prevention, generates individualized risk for anti-thrombotic therapy options based on individual clinical trials, and improves the accurate use of DOACs with adjusted dosage based on prescribing information fine-tuned for renal and other patient characteristics.
